8-K: Flora Growth Secures Flexible $2.12M ATM Equity Program

Flora Growth Corp. has entered into an 'at-the-market' sales agreement with Revere Securities LLC to raise up to $2.12 million for general corporate purposes.

Summary

• Flora Growth Corp. (the "Company") entered into an "at-the-market" (ATM) sales agreement with Revere Securities LLC (the "Agent") on September 23, 2025.
• The agreement allows the Company to sell common shares, with no par value, through the Agent as its sales agent.
• Sales will be conducted as an "at the market offering" as defined in Rule 415(a)(4) under the Securities Act of 1933.
• The Company is not obligated to make any sales under the agreement, retaining discretion over timing and volume.
• The Agent will use commercially reasonable efforts to sell common shares requested by the Company.
• Compensation to the Agent is tiered: 3.00% of the first $150 million in aggregate gross proceeds, 2.00% of the next $350 million, and 1.25% of gross proceeds exceeding $500 million.
• The Company intends to use the net proceeds, after deducting commissions and offering expenses, for general corporate purposes.
• The maximum aggregate offering price for common shares to be sold under this ATM Sales Agreement is US$2,120,000.

Sentiment

Score: 6

Explanation: The ATM offering provides Flora Growth Corp. with a flexible mechanism to raise capital for general corporate purposes, which is generally positive for financial stability and strategic options. However, it also introduces the potential for share dilution for existing shareholders, which can be a negative factor. The relatively small maximum offering amount suggests a measured approach to capital raising.

Positives

• Provides Flora Growth Corp. with a flexible and efficient mechanism to raise capital as needed, adapting to market conditions.
• Allows the company to access public markets for funding without the need for a traditional, potentially more costly, underwritten offering.
• Proceeds are designated for general corporate purposes, offering broad financial flexibility to support ongoing operations and strategic initiatives.

Negatives

• Potential for dilution of existing shareholders' equity as new common shares are sold into the market.
• Sales will be at prevailing market prices, which could be lower than a fixed-price offering, potentially impacting the average share price.
• The company will incur agent commissions and offering expenses, which will reduce the net proceeds received from the sales.
• The relatively small maximum offering amount of US$2,120,000 might indicate limited immediate capital needs or market capacity for larger raises.

Risks

• There is no assurance that the Sales Agent will be successful in selling Placement Shares, meaning the Company may not raise the desired capital.
• The Company bears sole responsibility for complying with limitations on the number or dollar amount of Placement Shares that may be issued and sold under the agreement.
• The Sales Agent is not obligated to purchase Placement Shares on a principal basis, limiting the Company's options if market demand is low.
• Sales of Placement Shares will be suspended if the Company is in possession of material non-public information, potentially delaying capital raising efforts.
• The agreement may be terminated by either party under specified conditions, including material adverse changes or trading suspensions on the Nasdaq Capital Market.
• Indemnification and contribution rights under the agreement may be limited by applicable law and public policy considerations.
• The U.S. federal income tax opinion provided is not binding on the Internal Revenue Service or a court, and changes in laws or facts could affect its validity.

Future Outlook

The company intends to use the net proceeds from the sale of common shares for general corporate purposes. It expects to continue to be in compliance with all Nasdaq Capital Market listing and maintenance requirements in the foreseeable future.

Industry Context

At-the-market (ATM) offerings are a common and flexible capital-raising tool for publicly traded companies, particularly those listed on exchanges like Nasdaq. This method allows companies to raise capital incrementally over time, adapting to market conditions, rather than through a single, large, and potentially disruptive offering. It is often favored by companies seeking to manage dilution and minimize market impact while maintaining financial flexibility.

Comparison to Industry Standards

• NA

Legal Proceedings

• The company represents that, except as disclosed in the Registration Statement and ATM Prospectus, there are no legal, governmental, or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries, or proceedings pending or threatened that could have a Material Adverse Effect on the company or its subsidiaries.

Related Party Transactions

• The company represents that, except as disclosed in the Registration Statement and ATM Prospectus, no relationship, direct or indirect, exists between the company/subsidiaries and directors, officers, shareholders, affiliates, customers, or suppliers that would require disclosure under the Securities Act.

Stakeholder Impact

• **Shareholders:** Potential for dilution due to the issuance of new common shares, but also benefits from the company's enhanced financial flexibility for general corporate purposes.
• **Company:** Gains a flexible and efficient method for capital raising, supporting ongoing operations and strategic initiatives.
• **Creditors:** Improved financial position and liquidity could enhance the company's ability to meet its obligations.

Next Steps

• The Company may issue Placement Notices to the Sales Agent to initiate sales of common shares.
• The Sales Agent will use commercially reasonable efforts to sell the Placement Shares as requested by the Company.
• Settlement for sales of Placement Shares will occur on the first trading day following the date of sale.
• The Company will file prospectus supplements with the SEC detailing the amount of Placement Shares sold, net proceeds, and compensation to the Sales Agent.
• The Company will make generally available an earnings statement to its security holders within 15 months after the end of the current fiscal quarter.

Key Dates

Recommendation

The establishment of an 'at-the-market' equity program provides Flora Growth Corp. with a flexible and efficient mechanism to raise capital for general corporate purposes. This enhances the company's financial liquidity and strategic optionality, which is a positive. However, the potential issuance of new common shares will lead to dilution for existing shareholders. Given that this filing primarily outlines a financing tool rather than reporting on operational performance or significant strategic shifts, a 'hold' recommendation is appropriate. Investors should monitor the actual utilization of this facility, the pricing of any shares sold, and subsequent financial reports to assess the impact on per-share metrics and the effectiveness of capital deployment.

Keywords

Flora Growth Corp, FLGC, at-the-market offering, ATM, equity financing, capital raise, common shares, Revere Securities LLC, SEC filing, dilution